Patient Empowerment: Engagement in the Development Lifecycle

Join us for a thought-provoking panel discussion as we explore the challenges and opportunities in involving patients in the whole life cycle management of a drug or a device.

In today's rapidly evolving healthcare landscape, patient involvement is more essential than ever. This discussion brings together experts from various fields—researchers, developers, healthcare providers, and patient advocates—to explore how a systematic approach can ensure patients' experiences, perspectives, and priorities are integrated into every stage of lifecycle management, from regulatory processes and clinical development to market access and commercial launch.
Our panelists will share their insights on the current state of patient engagement strategies and tools, highlighting both achievements and ongoing challenges. Afterward, we invite you to participate in an interactive, moderated Q&A session to further explore this critical topic.

Gabriele Brambilla, CEO,

Gabriele is the CEO of Alira Health, a global clinical, real-world solutions and consulting company. Alira Health's mission is to humanize healthcare and life sciences through innovative technologies and expert guidance. Mr. Brambilla's unwavering commitment to patient impact drives the company's unique ability to help its life sciences clients thrive in the new world of empowered and engaged patients.

Rose Blackburne, MD, VP, Global Head General Medicine, Global Product Development, Clinical Research,

Dr. Blackburne is a global life sciences executive with three decades of clinical leadership experience, including 12+ years as a practicing physician. She is an inaugural member of the FDA Patient Engagement Advisory Committee (PEAC) at the Centers for Devices and Radiologic Health (CDRH).

Ligia Del Bianco, Executive Director, Global Head of Patient Advocacy, Corporate Responsibility & Community Engagement,

Ligia is the Executive Director of the Biogen Foundation and Global Head of Patient Advocacy, Corporate Responsibility and Community Engagement. She oversees patient advocacy group engagement, Biogen’s philanthropic efforts, community outreach and partnerships with high-impact groups that prioritize health equity programs for the benefit of local communities.

Alissa Mendoza, Head of Patient Advocacy,

Alissa has 25 years of extensive experience in the pharmaceutical, biotech, and medical device arenas, specializing in medical affairs, patient/professional advocacy, and public policy. She has experience navigating complex government affairs environments and advocating for critical policies to produce positive health outcomes for individuals and advance organizational goals.

Wendy Erler, VP Global Head Patient Experience,

Wendy is a Global leader responsible for developing, implementing, and directing an enterprise-wide patient-centricity strategy to consistently and systematically engage patients and embed insights across the medicines lifecycle. Areas of focus include health equity and clinical trials designed to improve outcomes and access to meaningful therapies.

This timely event is crucial for anyone involved in the healthcare ecosystem, including researchers, investors, and clinicians interested in ensuring patient experiences, perspectives, and priorities are integrated into product development.

Host or Publisher New England Healthcare Executive Network